Two/CD rival/JJ bidders/NNS for/IN Connaught/NNP BioSciences/NNPS extended/VBD their/PRP$ offers/NNS to/TO acquire/VB the/DT Toronto-based/JJ vaccine/NN manufacturer/NN Friday/NNP ./.
Institut/NNP Merieux/NNP S.A./NNP ,/, which/WDT offered/VBD #/CD million/CD Canadian/JJ dollars/NNS -LRB-/-LRB- US$/$ #.#/CD million/CD -RRB-/-RRB- ,/, or/CC C$/$ #/CD a/DT share/NN for/IN Connaught/NNP ,/, said/VBD it/PRP would/MD extend/VB its/PRP$ bid/NN ,/, due/JJ to/TO expire/VB last/JJ Thursday/NNP ,/, to/TO Nov./NNP #/CD ./.
A/DT C$/$ #-a-share/JJ bid/NN by/IN Ciba-Geigy/NNP Ltd./NNP ,/, a/DT pharmaceutical/JJ company/NN based/VBN in/IN Basel/NNP ,/, Switzerland/NNP ,/, and/CC California-based/JJ Chiron/NNP Corp./NNP ,/, a/DT bioresearch/NN concern/NN ,/, was/VBD extended/VBN to/TO Nov./NNP #/CD ./.
It/PRP had/VBD been/VBN due/JJ to/TO expire/VB Friday/NNP evening/NN ./.
Merieux/NNP previously/RB said/VBD it/PRP would/MD ensure/VB its/PRP$ bid/NN remained/VBD open/JJ pending/VBG a/DT final/JJ decision/NN by/IN Canadian/JJ regulators/NNS on/IN whether/IN to/TO approve/VB the/DT takeover/NN ./.
Merieux/NNP ,/, a/DT vaccine/NN and/CC bioresearch/NN firm/NN based/VBN in/IN Lyon/NNP ,/, France/NNP ,/, is/VBZ controlled/VBN #.#/CD %/NN by/IN state-owned/JJ Rhone/NNP Poulenc/NNP S.A/NNP ./.
The/DT Canadian/JJ government/NN previously/RB said/VBD Merieux/NNP 's/POS bid/NN did/VBD n't/RB offer/VB enough/RB ``/`` net/JJ benefit/NN ''/'' to/TO Canada/NNP to/TO be/VB approved/VBN ,/, and/CC gave/VBD Merieux/NNP an/DT until/IN mid-November/NNP to/TO submit/VB additional/JJ information/NN ./.
Merieux/NNP officials/NNS said/VBD last/JJ week/NN that/IN they/PRP are/VBP ``/`` highly/RB confident/JJ ''/'' the/DT offer/NN will/MD be/VB approved/VBN once/IN it/PRP submits/VBZ details/NNS of/IN its/PRP$ proposed/VBN investments/NNS to/TO federal/JJ regulators/NNS ./.
Both/DT offers/NNS are/VBP conditional/JJ on/IN regulatory/JJ approvals/NNS and/CC enough/JJ shares/NNS being/VBG tendered/VBN to/TO give/VB the/DT bidders/NNS a/DT majority/NN of/IN Connaught/NNP 's/POS shares/NNS outstanding/JJ ./.
Institut/NNP Merieux/NNP ,/, which/WDT already/RB holds/VBZ a/DT #.#/CD %/NN stake/NN in/IN Connaught/NNP ,/, said/VBD that/IN at/IN the/DT close/NN of/IN business/NN Thursday/NNP ,/, #,#,#/CD shares/NNS of/IN Connaught/NNP and/CC C$/$ #.#/CD million/CD face/NN amount/NN of/IN debentures/NNS ,/, convertible/JJ into/IN #,#,#/CD common/JJ shares/NNS ,/, had/VBD been/VBN tendered/VBN to/TO its/PRP$ offer/NN ./.
At/IN the/DT close/NN of/IN business/NN Thursday/NNP ,/, Ciba-Geigy/NNP and/CC Chiron/NNP said/VBD #,#/CD common/JJ shares/NNS had/VBD been/VBN tendered/VBN to/TO their/PRP$ offer/NN ./.
At/IN last/JJ report/NN ,/, Connaught/NNP had/VBD #.#/CD million/CD shares/NNS outstanding/JJ ./.
Separately/RB ,/, the/DT Ontario/NNP Supreme/NNP Court/NNP said/VBD it/PRP will/MD postpone/VB indefinitely/RB a/DT ruling/NN on/IN the/DT lawsuit/NN launched/VBN by/IN the/DT University/NNP of/IN Toronto/NNP against/IN Connaught/NNP in/IN connection/NN with/IN the/DT Merieux/NNP bid/NN ./.
In/IN a/DT statement/NN prepared/VBN by/IN lawyers/NNS for/IN the/DT university/NN and/CC Connaught/NNP ,/, the/DT parties/NNS said/VBD they/PRP agreed/VBD that/IN as/IN a/DT result/NN of/IN reaching/VBG a/DT C/$ #/CD million/CD research/NN accord/NN ,/, ``/`` It/PRP is/VBZ unnecessary/JJ that/IN there/EX be/VB a/DT judgment/NN on/IN the/DT merits/NNS -LCB-/-LRB- of/IN the/DT case/NN -RCB-/-RRB- at/IN this/DT time/NN ./. ''/''
Lawyers/NNS for/IN the/DT two/CD sides/NNS were/VBD n't/RB immediately/RB available/JJ for/IN comment/NN ./.
The/DT university/NN had/VBD sought/VBN an/DT injunction/NN blocking/VBG Connaught/NNP 's/POS board/NN from/IN recommending/VBG or/CC supporting/VBG an/DT offer/NN for/IN the/DT company/NN by/IN Merieux/NNP ./.
